e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Pulmonary circulation II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients
S. Pizarro, V. I. Peinado, M. Vives, M. Diez, E. Ferrer, L. Molins, Y. Torralba, R. Rodríguez-Roisin, J. Roca, J. A. Barberà (Barcelona, Spain)
Source:
Annual Congress 2010 - Pulmonary circulation II
Session:
Pulmonary circulation II
Session type:
Thematic Poster Session
Number:
1120
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Pizarro, V. I. Peinado, M. Vives, M. Diez, E. Ferrer, L. Molins, Y. Torralba, R. Rodríguez-Roisin, J. Roca, J. A. Barberà (Barcelona, Spain). Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients. Eur Respir J 2010; 36: Suppl. 54, 1120
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Distinct patterns of circulating endothelial cells in pulmonary hypertension
Source: Eur Respir J 2010; 36: 1284-1293
Year: 2010
Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Decreased number of circulating endothelial progenitor cells in patients with emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
Effects of training on endothelial function and circulating endothelial progenitor cells in COPD patients
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
Source: Eur Respir J 2006; 27: 529-541
Year: 2006
Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results)
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Increased levels of circulating endothelial progenitor cells during exacerbations of COPD
Source: Annual Congress 2007 - Biomarkers and assessment of COPD
Year: 2007
Nestin expressing progenitor cells in pulmonary vasculature
Source: Annual Congress 2011 - Experimental pulmonary hypertension
Year: 2011
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
Source: Eur Respir J 2011; 37: 1392-1399
Year: 2011
Circulating fibrocytes are increased in children and young adults with pulmonary hypertension
Source: Eur Respir J 2011; 39: 104-111
Year: 2012
Circulating fibrocytes are increased in children and young adults with pulmonary hypertension
Source: Eur Respir J 2012; 39: 104-111
Year: 2012
Effect of targeted therapy on circulating endothelial progenitor cells in precapillary pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
CD133+ cells in pulmonary arterial hypertension
Source: Eur Respir J 2016; 48: 459-469
Year: 2016
Fluorescence activated cell sorting for simultaneous assessment of nine surface markers of circulating endothelial progenitor cells in pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012
Endothelial progenitor cells (EPC) in patients with chronic bronchitis or COPD
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Human pulmonary arterial hypertension bone marrow-derived CD133+ myeloid progenitors induce vascular remodeling in immunodeficient mice
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011
Circulating endothelial progenitor cells and chronic pulmonary diseases
Source: Eur Respir J 2011; 37: 426
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept